Company Filing History:
Years Active: 2018
Title: Upneet Sokhi: Innovator in Cancer Therapeutics
Introduction
Upneet Sokhi is a prominent inventor based in Richmond, VA, who has made significant contributions to the field of cancer therapeutics. She is known for her innovative approach to developing recombinant therapeutic cytokines, which have the potential to revolutionize cancer treatment.
Latest Patents
Upneet Sokhi holds a patent for a recombinant cancer therapeutic cytokine. This invention involves recombinant therapeutic cytokines, referred to as 'therakines,' designed for the treatment of cancer. The therakines include a truncated region of MDA-7/TL-24 ('M4') that is not typically found in nature but exhibits anti-cancer activity. Additionally, these therakines possess a secretory signal that facilitates their secretion from both normal and cancer cells. The interaction of therakines with MDA-7/IL-24 receptors on adjacent and distant cancer cells leads to bystander killing of the target cancer cell, as well as neighboring and distant cancer cells.
Career Highlights
Upneet Sokhi is affiliated with Virginia Commonwealth University, where she continues her research and development in cancer therapeutics. Her work is characterized by a commitment to advancing medical science and improving patient outcomes through innovative solutions.
Collaborations
Some of her notable coworkers include Paul B. Fisher and Praveen Bhoopathi, who contribute to her research efforts and collaborative projects.
Conclusion
Upneet Sokhi's work in developing recombinant therapeutic cytokines represents a significant advancement in cancer treatment. Her innovative approach and dedication to research continue to inspire progress in the field of oncology.